The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients - Arnaud Del Bello; Joseph Cachoux; Florence Abravanel; Thomas Prudhomme; Nassim Kamar (Kidney International Reports)